Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial
Stem Cells Translational Medicine · 2024
DOI: 10.1093/stcltm/szae026 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Stem Cells Translational Medicine, 2024. Verfasst von Ricardo de Souza Tesch und 14 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Laboratory, Petrópolis Medical School/ UNIFASE, Avenida Barão do Rio Branco 1003, Centro, Petrópolis, RJ 25680-120, Brazil. Hauptthemen laut MEDLINE: Nasal Septum, Mandibular Condyle. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Octacilio Gualberto Foundation (FOG), Rio de Janeiro State Research Support Foundation (FAPERJ).
Abstract (Originalsprache)
Condylar resorption is an aggressive and disability form of temporomandibular joint (TMJ) degenerative disease, usually non-respondent to conservative or minimally invasive therapies and often leading to surgical intervention and prostheses implantation. This condition is also one of the most dreaded postoperative complications of orthognathic surgery, with severe cartilage erosion and loss of subchondral bone volume and mineral density, associated with a painful or not inflammatory processes. Because regenerative medicine has emerged as an alternative for orthopedic cases with advanced degenerative joint disease, we conducted a phase I/IIa clinical trial (U1111-1194-6997) to evaluate the safety and efficacy of autologous nasal septal chondroprogenitor cells. Ten participants underwent biopsy of the nasal septum cartilage during their orthognathic surgery. The harvested cells were cultured in vitro and analyzed for viability, presence of phenotype markers for mesenchymal stem and/or chondroprogenitor cells, and the potential to differentiate into chondrocytes, adipocytes, and osteoblasts. After the intra-articular injection of the cell therapy, clinical follow-up was performed using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and computed tomography (CT) images. No serious adverse events related to the cell therapy injection were observed during the 12-month follow-up period. It was found that autologous chondroprogenitors reduced arthralgia, promoted stabilization of mandibular function and condylar volume, and regeneration of condylar tissues. This study demonstrates that chondroprogenitor cells from the nasal septum may be a promise strategy for the treatment of temporomandibular degenerative joint disease that do not respond to other conservative therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regenerative Medicine Laboratory, Petrópolis Medical School/ UNIFASE, Avenida Barão do Rio Branco 1003, Centro, Petrópolis, RJ 25680-120, Brazil.
- Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Ave. Carlos Chagas Filho 373, Sala B1-011, Cidade Universitária, Ilha Do Fundão, Rio de Janeiro, RJ 21941-590, Brazil.
- Core for Cell Technology, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Prado Velho, Curitiba, PR 80215-901, Brazil.
- Stem Cells Basic Biology Laboratory, Carlos Chagas Institute - FIOCRUZ/PR, Rua Professor Algacyr Munhoz Mader, 3775, Curitiba, PR, 81350-010, Brazil.
- Postgraduate Program in Exercise and Sport Sciences, State University of Rio de Janeiro, Rua São Francisco Xavier 524, Maracanã, Rio de Janeiro, RJ, 20550-013, Brazil.
- Department of Specific Formation, School of Dentistry, Health Institute of Nova Friburgo, Fluminense Federal University, Rua Dr. Silvio Henrique Braune, 22, Nova Friburgo, RJ, 28625-650, Brazil.
ORCID-Profile: Ricardo de Souza Tesch
Förderung
- Octacilio Gualberto Foundation (FOG)
- Rio de Janeiro State Research Support Foundation (FAPERJ)
Zitieren
APA
Tesch, R. S., Takamori, E. R., Menezes, K., Carias, R. B. V., Rebelatto, C. L. K., Senegaglia, A. C., Daga, D. R., Fracaro, L., Robert, A. W., Pinheiro, C. B. R., Aguiar, M. F., Blanco, P. J., Zilves, E. G., Brofman, P. R. S., & Borojevic, R. (2024). Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae026
Vancouver
Tesch RS, Takamori ER, Menezes K, Carias RBV, Rebelatto CLK, Senegaglia AC, et al. Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial. Stem Cells Translational Medicine. 2024. doi:10.1093/stcltm/szae026
BibTeX
@article{Tesch2024,
author = {Tesch, Ricardo de Souza and Takamori, Esther Rieko and Menezes, Karla and Carias, Rosana Bizon Vieira and Rebelatto, Carmen Lucia Kuniyoshi and Senegaglia, Alexandra Cristina and Daga, Debora Regina and Fracaro, Leticia and Robert, Anny Waloski and Pinheiro, Carlos Bruno Reis and Aguiar, Marcelo de Freitas and Blanco, Pablo Javier and Zilves, Eduardo Guerreiro and Brofman, Paulo Roberto Slud and Borojevic, Radovan},
title = {Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial},
journal = {Stem Cells Translational Medicine},
year = {2024},
doi = {10.1093/stcltm/szae026}
}
EUVIMED